ClinicalTrials.Veeva

Menu

Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)

O

Office of Rare Diseases (ORD)

Status

Completed

Conditions

Hereditary Ataxia

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00004306
199/11796

Details and patient eligibility

About

OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies.

II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.

Full description

PROTOCOL OUTLINE: Participants undergo a comprehensive clinical and molecular evaluation. Studies include: neurologic evaluation, including magnetic resonance imaging and nerve conduction studies; ophthalmologic exam; audiologic exam, including auditory brain stem evoked response; DNA extraction from blood, skin and muscle; genotype phenotype correlation.

A neuropathologic evaluation is conducted postmortem, when possible.

Enrollment

18 patients

Sex

All

Ages

3+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subjects who have the diagnosis of SCA10 and their immediate relatives.

Exclusion criteria

Children under 3 years of age, pregnant women, prisoners, mentally incapacitated subjects, and subjects who do not give consent.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems